Intet billede af Søren Skov

Søren Skov

19942019

Publikationer pr. år

Netværk

Maria Dimaki

  • Department of Micro- and Nanotechnology, Technical University of Denmark
  • University of Copenhagen
  • Danmarks Tekniske Universitet

Ekstern person

Winnie Edith Svendsen

  • Department of Micro- and Nanotechnology, Technical University of Denmark
  • Danmarks Tekniske Universitet

Ekstern person

Brian Fox

  • Novo Nordisk A/S (Biz)

Ekstern person

Kyle Serikawa

  • Novo Nordisk A/S (Biz)
  • Novo Nordisk Research Centre

Ekstern person

Irene Mueller-Harvey

  • University of Reading

Ekstern person

Dorota Kwasny

  • Department of Micro- and Nanotechnology, Technical University of Denmark

Ekstern person

Indumathi Vedarethinam

  • Department of Micro- and Nanotechnology, Technical University of Denmark

Ekstern person

Pranjul Jaykumar Shah

  • Department of Micro- and Nanotechnology, Technical University of Denmark

Ekstern person

Gabriele Schramm

  • Research Center Borstel Leibniz-Center for Medicine and Biosciences

Ekstern person

A. D. Christensen

  • Novo Nordisk A/S (Biz)

Ekstern person

Mette Thorn

  • Novo Nordisk A/S (Biz)

Ekstern person

Silje Haukali Omland

  • University of Copenhagen

Ekstern person

Lasse Folkersen

  • Karolinska Institutet

Ekstern person

Tina Z. Jørgensen

  • Laboratory of Immunology, Faculty of Medical and Health Sciences, University of Copenhagen (Stud.)

Ekstern person

Kerstin Skovgaard

  • National Veterinary Institute, Technical University of Denmark, Copenhagen
  • Technical University of Denmark
  • Danmarks Tekniske Universitet

Ekstern person

M. Jørgensen

  • Technical University of Denmark

Ekstern person

Anneline Nansen

  • Novo Nordisk A/S (Biz)
  • Zealand Pharma A/S (Biz)

Ekstern person

Aina Ramsay

  • Chemistry and Biochemistry Laboratory, School of Agriculture, Policy and Development, University of Reading, Reading, United Kingdom.

Ekstern person

Mette Thorn

  • Technical University of Denmark

Ekstern person

Søren Haase

  • Department of Immunopharmacology, Novo Nordisk A/S

Ekstern person

Bo Wiinberg

  • Novo Nordisk A/S (Biz)

Ekstern person

Brian Fox

  • Immunexpress, Seattle

Ekstern person

Martin Iain Bahl

  • Division of Microbiology and Risk Assessment

Ekstern person

Haruhiko Maruyama

  • Department of Infectious Diseases, Division of Parasitology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan

Ekstern person

Christos Fryganas

  • School of Biological Sciences, University of Reading, Reading, UK

Ekstern person

Thomas L. Holm

  • Novo Nordisk A/S (Biz)

Ekstern person

Shameek Biswas

  • Novo Nordisk A/S (Biz)
  • Novo Nordisk Research Centre

Ekstern person

Tine Rask Licht

  • Division of Microbiology and Risk Assessment

Ekstern person

G. Houen

  • Statens Serum Institut

Ekstern person

Karin Dreisig

  • University of Copenhagen

Ekstern person

Rannveig Viste

  • University of Oslo

Ekstern person

M. Tranholm

  • Haemostasis Pharmacology, Novo Nordisk A/S, Måløv

Ekstern person

Lisa C. Laan

  • VU University Medical Center

Ekstern person

Luis Caraballo

  • Institute for Immunological Research, University of Cartagena, Cartagena, Colombia

Ekstern person

Hanne Norsgaard

  • LEO Pharma AS

Ekstern person

C. Haase

  • Novo Nordisk A/S (Biz)

Ekstern person

Ute Hoffmann

  • Deutsches Rheuma-Forschungszentrum and Charité- Universitätsmedizin Berlin

Ekstern person

Elsenoor J. Klaver

  • VU University Medical Center

Ekstern person

M.B.B. Larsen

  • Technical University of Denmark

Ekstern person

Maja Wallentin Dommer

  • University of Copenhagen

Ekstern person

Christos Fryganas

  • Chemistry and Biochemistry Laboratory, School of Agriculture, Policy and Development, University of Reading, Reading, United Kingdom.

Ekstern person

Karsten Buschard

  • University of Copenhagen

Ekstern person

Lars Hornum

  • Novo Nordisk Foundation

Ekstern person

Nikolaj Pagh Kristensen

  • University of Copenhagen

Ekstern person

Pernille Autzen Usher

  • Novo Nordisk A/S (Biz)

Ekstern person

Louise Sund

  • University of Copenhagen

Ekstern person

Claus Haase

  • Novo Nordisk A/S (Biz)

Ekstern person

K. Duus

  • Statens Serum Institut

Ekstern person

Emil Bach

  • Laboratory of Genomics and Molecular Biomedicine, Department of Biology, University of Copenhagen

Ekstern person

Per Thor Straten

  • University of Copenhagen

Ekstern person

Kim Holmstrøm

  • Bioneer A/S

Ekstern person

Wiktor Majewski

  • University of Copenhagen

Ekstern person

Kyle Serikawa

  • Benaroya Research Institute

Ekstern person

Jens Nielsen

  • Technical University of Denmark

Ekstern person

Esther van Andel

  • Institut for Veterinær Sygdomsbiologi, Københavns Universitet

Ekstern person

Tove N. Clausen

  • Danish Fur Breeders Research Center

Ekstern person

Bo Wiinberg

  • Novo Nordisk A/S (Biz)

Ekstern person

Lars Blom

  • Copenhagen University Hospital, Gentofte

Ekstern person

Zeynep Tümer

  • Kennedy Center

Ekstern person

Marja Jäättelä

  • Forskningscenter Risø
  • Danish Cancer Society

Ekstern person

Martin Iain Bahl

  • Division of Microbiology and Risk Assessment

Ekstern person